|
000
| 02162nam 2200409zi 4500 |
|---|
| 001 | 9.913037 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20240823080903 |
|---|
| 006 | m o d f |
|---|
| 007 | cr mn||||||||| |
|---|
| 008 | 220705t20242024onc ob f000 0 eng d |
|---|
| 020 | |a9780660444086 |
|---|
| 040 | |aCaOODSP|beng|erda|cCaOODSP |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aH139-43/2024E-PDF |
|---|
| 245 | 00|aAnnex 3A to the Good manufacturing practices guide : |bschedule C drugs (GUI-0026). |
|---|
| 250 | |aVersion 3 |
|---|
| 264 | 1|a[Ottawa] : |bHealth Canada = Santé Canada,|c2024. |
|---|
| 264 | 4|c©2024 |
|---|
| 300 | |a1 online resource (22 pages) |
|---|
| 336 | |atext|btxt|2rdacontent |
|---|
| 337 | |acomputer|bc|2rdamedia |
|---|
| 338 | |aonline resource|bcr|2rdacarrier |
|---|
| 500 | |aCover title. |
|---|
| 500 | |aDate issued and implemented: 3 July 2024. |
|---|
| 500 | |aReplaces: Guidance document Annex 3 to the current edition of the Good manufacturing practices guidelines - schedule C drugs (GUI-0026), 19 November 2010. |
|---|
| 500 | |aIssued also in French under title: Annexe 3A des Lignes directrices sur les bonnes pratiques de fabrication : drogues de l'annexe C (GUI-0026). |
|---|
| 504 | |aIncludes bibliographical references (page 22). |
|---|
| 520 | |a"This document is for people who work with Schedule C drugs (radiopharmaceuticals) as: fabricators, packagers, labellers, testers, distributors, importers. The annex will help you understand and comply with Part C, Division 2 of the Food and Drug Regulations"--Purpose, page 5. |
|---|
| 650 | 0|aRadiopharmaceuticals|zCanada. |
|---|
| 650 | 0|aDrugs|xLaw and legislation|zCanada. |
|---|
| 650 | 0|aDrug factories|zCanada. |
|---|
| 710 | 1 |aCanada. |bHealth Canada, |eissuing body. |
|---|
| 775 | 08|tAnnexe 3A des Lignes directrices sur les bonnes pratiques de fabrication : |w(CaOODSP)9.913040 |
|---|
| 856 | 40|qPDF|s378 KB|uhttps://publications.gc.ca/collections/collection_2024/sc-hc/H139-43-2024-eng.pdf |
|---|
| 856 | 4 |qHTML|sN/A|uhttps://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/good-manufacturing-practices/guidance-documents/annex-3-current-edition-guidelines-schedule-drugs-0026.html |
|---|